Tage Honore, Director of Vanda Pharmaceuticals VNDA, has filed 0 purchases and 1 sale on the open market. Over the past 12 months that comes to a net sale of $240.9K. The latest trade was on 06/04.

TH

TH

Tage Honore

Director

Company

Vanda Pharmaceuticals VNDA

First filing

23/03/17

Trades

9 trades

Buys / sales

0 / 1

12-month net buying

−$240.9K

Last trade

06/04

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Vanda PharmaceuticalsVNDA	Open-market sale	02/23	02/24	30,000 sh	$8.03	$240,900	−24.3%